BioSpace News Archive

Business

Economic Constriction has Fallout on Investments, IPOs and Collaborations

As the macro pressures of higher rates and fear of recession build, today’s investor is increasingly risk averse. With zero-risk options offering decent returns, only the highest-quality programs will get funding.

February 28, 2023

·

2 min read

·

Kate Goodwin

Drug Development

Theravance Cuts JAK Inhibitor, 17% of Workforce in Wake of Shareholder Letter

Theravance Biopharma is discontinuing research activities for its JAK inhibitor program in lung inflammation and reducing its headcount by about 17%.

February 28, 2023

·

2 min read

·

Tristan Manalac

Drug Development

Aptinyx’ Losing Streak Continues as Parkinson’s Candidate Falls Short

Aptinyx’s NYX-458 fell short of the primary endpoint in a Phase II trial of patients with cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.

February 28, 2023

·

2 min read

·

Tristan Manalac

Peter Maag, Ph.D., James Chung, M.D., Ph.D./Kyver

Drug Development

Kyverna and Cabaletta are Repurposing CAR-T for Autoimmune Diseases

Researchers at Kyverna Therapeutics and Cabaletta Bio hope to repurpose CAR-T cell therapy for patients with autoimmune diseases.

February 28, 2023

·

3 min read

·

Hayley Shasteen

Job Trends

AstraZeneca Rare Disease R&D Expansion Adds 500 Jobs At New Hub

On Rare Disease Day, Feburary 28, AstraZeneca announced the creation of the Alexion, AstraZeneca Rare Disease Development Hub in Toronto, Ontario.

February 28, 2023

·

2 min read

·

Tristan Manalac

Career Advice

What You Need to Know About Rage Applying

A variation of rage quitting, rage applying is a method of job searching that occurs when someone applies for many new roles while still employed in their current position.

February 28, 2023

·

3 min read

·

Franklin Carpenter

Career Advice

Career Advancement Tips for Pharmaceutical Sales Reps

Find out what it takes to become a successful pharma sales rep and discover helpful career advancement tips for pharmaceutical sales representatives.

February 28, 2023

·

5 min read

·

Don Potochny

FDA

FDA Approves First Therapy for Friedreich’s Ataxia (Updated)

The FDA greenlit Reata Pharmaceuticals’ omaveloxolone (Skyclarys) as the first and only treatment for Friedreich’s ataxia, a rare, life-limiting neuromuscular disorder.

February 28, 2023

·

4 min read

·

Heather McKenzie

Business

Roche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics

Roche‌ announced the expansion of its collaboration with the U.S. Centers for Disease Control and Prevention to strengthen laboratory capabilities in countries greatly affected by the HIV and tuberculosis epidemics.

February 28, 2023

·

6 min read

Drug Development

OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease

OKYO Pharma Limited announced that its GMP packaged OK-101 drug to be used in the upcoming Phase 2, first-in-human, clinical trial in patients with DED, which was recently shipped from Europe, has cleared customs in the United States.

February 28, 2023

·

3 min read